收稿日期: 2023-09-07
网络出版日期: 2024-04-19
基金资助
四川省中央引导地方科技发展专项项目(科技创新基地建设)(2023ZYD0168)
The effect of target controlled infusion of sufentanil or remifentanil on postoperative pain relief and recovery in patients undergoing daytime laparoscopic cholecystectomy
Received date: 2023-09-07
Online published: 2024-04-19
目的 比较靶控输注舒芬太尼与传统瑞芬太尼用于改善日间腹腔镜胆囊切除术患者术后镇痛和恢复质量的有效性和安全性。 方法 本研究为一项前瞻性随机对照研究,选取2019年10月至2022年10月在晋中市第一人民医院日间病房行腹腔镜胆囊切除术的100例患者作为观察对象。采用随机数字法将患者分为两组,50例患者术中靶控输注瑞芬太尼(常规组),50例患者术中靶控输注舒芬太尼(观察组)。观察两组患者术后疼痛、恶心呕吐、自主呼吸恢复时间、苏醒时间、拔管时间,恢复定向力所用时间,以及围手术期[麻醉诱导前(T0)、麻醉诱导后5 min(T1)、插管操作时(T2)、切皮(T3)、入腹观察时(T4)、拔管时(T5)时]的血压、心率等变化。 结果 观察组术后3 h内视觉模拟评分(visual analogue scale, VAS)低于常规组(P < 0.05)。但观察组自主呼吸恢复时间、苏醒时间、拔管时间及定向力恢复时间相较于常规组更长(P < 0.05)。麻醉诱导后5 min(T1)常规组血压低于观察组,在拔管时(T5),常规组血压、心率高于观察组(P < 0.05)。两组患者围术期不良事件发生率无差异。 结论 对日间腹腔镜胆囊切除术患者,靶控输注舒芬太尼,具有血流动力学更加平稳、镇痛效能发挥显著的优点,但由于延长患者术后恢复时间,所以需提前停药。
李开瑜 , 汤敏誉 , 梁鹏 . 靶控输注舒芬太尼或瑞芬太尼对日间腹腔镜胆囊切除术患者术后镇痛和恢复的影响[J]. 实用医学杂志, 2024 , 40(8) : 1074 -1077 . DOI: 10.3969/j.issn.1006-5725.2024.08.009
Objective The study tried to compare the effectiveness and safety of target controlled infusion of sufentanil with traditional remifentanil in improving postoperative pain relief and recovery quality in patients undergoing daytime laparoscopic cholecystectomy. Methods This study is a prospective randomized controlled study, which selecting 100 patients who underwent laparoscopic cholecystectomy in the day ward of our hospital from October 2019 to October 2022 as the observation subjects. Patients were divided into two groups using a random digitization method, with 50 patients receiving intraoperative target controlled infusion of remifentanil (conventional group) and 50 patients receiving intraoperative target controlled infusion of sufentanil (study group). Observe the postoperative pain, nausea and vomiting, spontaneous breathing recovery time, awakening time, extubation time, directional force recovery time, as well as changes in blood pressure and heart rate during the perioperative period (before anesthesia induction (T0), 5 minutes after anesthesia induction (T1), intubation operation (T2), skin incision (T3), abdominal observation (T4), and extubation (T5) in two groups of patients. Results The visual analog scale (VAS) within 3 hours after surgery in the study group was lower than that in the control group (P < 0.05). However, the recovery time of spontaneous breathing, awakening time, extubation time, and directional force recovery time in the research group were longer than those in the conventional group (P < 0.05). After 5 minutes of anesthesia induction (T1), the blood pressure in the control group was lower than that in the study group. At extubation (T5), the blood pressure and heart rate in the control group were higher than those in the study group (P < 0.05). There was no difference in the incidence of perioperative adverse events between the two groups of patients. Conclusions Targeted infusion of sufentanil for patients undergoing daytime laparoscopic cholecystectomy has the advantages of smoother hemodynamics and significant analgesic effects. However, early discontinuation of the medication is necessary due to the prolonged postoperative recovery time of patients.
| 1 | 中华医学会麻醉学分会. 日间手术麻醉指南[J]. 中华医学杂志, 2023, 103(43): 3462-3471. doi:10.3760/cma.j.cn112137-20230803-00151 |
| 2 | 赵艳, 唐慧敏. 靶控输注不同低效应室浓度舒芬太尼复合丙泊酚用于腹腔镜手术麻醉的效果 [J]. 中华麻醉学杂志, 2020,40 (7): 830-833. doi:10.3760/cma.j.cn131073.20200328.00715 |
| 3 | 《中华消化外科杂志》编辑委员会. 日间手术肝胆疾病标准化流程中国专家共识(2022版)[J]. 中华消化外科杂志, 2022,21(2):185-190. |
| 4 | OGAWA T, TOMODA T, KATO H,et al. Propofol sedation with a target-controlled infusion pump in elderly patients undergoing ERCP[J]. Gastrointest Endosc, 2020,92(2):301-307. doi:10.1016/j.gie.2020.03.002 |
| 5 | 谭卫卫,王祥,郭宗峰,等. 舒芬联合瑞芬太尼靶控输注对结直肠癌根治术患者的疗效及对其疼痛应激及血流动力学的影响分析[J]. 湖南师范大学学报(医学版), 2020,17(3):111-114. |
| 6 | 程智刚,姜媛,王云姣,等. 规范日间手术麻醉管理[J]. 国际麻醉学与复苏杂志, 2021,42(12):1237-1239. doi:10.3760/cma.j.cn321761-20211114-00425 |
| 7 | 马虹,马爽,邓小明,等. 麻醉科质量控制专家共识[A/OL]. (2021-7-5) [2022-10-28]. . |
| 8 | BICKER J, ALVES G, FALC?O A, et al. Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics[J].Br J Pharmacol,2020,177(10):2215-2239. doi:10.1111/bph.15017 |
| 9 | KLEIN A A, MEEK T, ALLCOCK E, et al.Recommendations for standards of monitoring during anaesthesia and recovery 2021: Guideline from the Association of Anaesthetists[J]. Anaesthesia, 2021,76(9):1212-1223. doi:10.1111/anae.15501 |
| 10 | 中华医学会麻醉学分会“成人日间手术加速康复外科麻醉管理专家共识”工作小组. 成人日间手术加速康复外科麻醉管理专家共识[J]. 协和医学杂志, 2019,10(6):562-569. |
| 11 | 李睿昫,李俊. 靶控输注舒芬太尼和瑞芬太尼用于妇科腹腔镜手术麻醉的临床效果探讨[J]. 中国医药科学,2019,9(17):135-138. doi:10.3969/j.issn.2095-0616.2019.17.039 |
| 12 | 中华医学会外科学分会,中华医学会麻醉学分会. 加速康复外科中国专家共识暨路径管理指南(2018)[J]. 中华麻醉学杂志, 2018,38(1):8-33. |
| 13 | PRICE A J, ALVAND A, TROELSEN A,et al. Knee replacement[J]. Lancet, 2018,392(10158):1672-1682. doi:10.1016/s0140-6736(18)32344-4 |
| 14 | 李敏. 瑞芬太尼与舒芬太尼靶控输注在腹腔镜手术麻醉中作用的对比分析[J]. 中外医学研究, 2019,17(16):26-28. |
| 15 | 杨燕,陈鑫,惠娜. ERAS在腹腔镜胆囊切除术患者中应用效果的Meta分析[J]. 临床医学研究与实践, 2023,8(2):110-115. |
| 16 | NECKEBROEK M, BOLDINGH J H L, DE SMET T,et al. Influence of remifentanil on the control performance of the bispectral index controlled bayesian-based closed-loop system for propofol administration[J]. Anesth Analg, 2020,130(6):1661-1669. doi:10.1213/ane.0000000000004208 |
| 17 | WANG X, WANG T, TIAN Z, et al. Asleep-awake-asleep regimen for epilepsy surgery:a prospective study of target-controlled infusion versus manually controlled infusion technique[J]. J Clin Anesth, 2016,32(2):92-100. doi:10.1016/j.jclinane.2015.11.014 |
| 18 | VELLINGA R, HANNIVOORT L N, INTRONA M,et al. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia[J]. Br J Anaesth,2021,126(2):386-394. doi:10.1016/j.bja.2020.10.027 |
| 19 | 肖丽珠,邹小华,钟涛,等. 不同靶浓度瑞芬太尼对丙泊酚闭环靶控输注稳定性的影响[J]. 临床麻醉学杂志, 2020,36(12):1186-1190. doi:10.12089/jca.2020.12.010 |
| 20 | 李亦凡,刘智慧,童贻捷. 靶控输注舒芬太尼和瑞芬太尼复合麻醉在腹腔镜结直肠癌根治术中的应用效果[J]. 实用临床医药杂志,2020,24(19):114-117. |
/
| 〈 |
|
〉 |